Literature DB >> 21092922

Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation.

Miora Feinstein1, Barak Markus, Iris Noyman, Hannah Shalev, Hagit Flusser, Ilan Shelef, Keren Liani-Leibson, Zamir Shorer, Idan Cohen, Shareef Khateeb, Sara Sivan, Ohad S Birk.   

Abstract

Pelizaeus-Merzbacher disease is an X-linked hypomyelinating leukodystrophy caused by PLP1 mutations. A similar autosomal-recessive phenotype, Pelizaeus-Merzbacher-like disease (PMLD), has been shown to be caused by homozygous mutations in GJC2 or HSPD1. We report a consanguineous Israeli Bedouin kindred with clinical and radiological findings compatible with PMLD in which linkage to PLP1, GJC2, and HSPD1 was excluded. Through genome-wide homozygosity mapping and mutation analysis, we demonstrated in all affected individuals a homozygous frameshift mutation that fully abrogates the main active domain of AIMP1, encoding ARS-interacting multifunctional protein 1. The mutation fully segregates with the disease-associated phenotype and was not found in 250 Bedouin controls. Our findings are in line with the previously demonstrated inability of mutant mice lacking the AIMP1/p43 ortholog to maintain axon integrity in the central and peripheral neural system.
Copyright © 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21092922      PMCID: PMC2997381          DOI: 10.1016/j.ajhg.2010.10.016

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

1.  Online system for faster multipoint linkage analysis via parallel execution on thousands of personal computers.

Authors:  M Silberstein; A Tzemach; N Dovgolevsky; M Fishelson; A Schuster; D Geiger
Journal:  Am J Hum Genet       Date:  2006-05-01       Impact factor: 11.025

Review 2.  Neurofilament phosphorylation: a new look at regulation and function.

Authors:  R A Nixon; R K Sihag
Journal:  Trends Neurosci       Date:  1991-11       Impact factor: 13.837

3.  SMART, a simple modular architecture research tool: identification of signaling domains.

Authors:  J Schultz; F Milpetz; P Bork; C P Ponting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach.

Authors:  M S van der Knaap; S N Breiter; S Naidu; A A Hart; J Valk
Journal:  Radiology       Date:  1999-10       Impact factor: 11.105

5.  A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease.

Authors:  Leonardo Salviati; Eva Trevisson; Maria Cristina Baldoin; Irene Toldo; Stefano Sartori; Milena Calderone; Romano Tenconi; AnnaMaria Laverda
Journal:  Neurogenetics       Date:  2006-10-10       Impact factor: 2.660

6.  Aminoacyl-tRNA synthetase-interacting multi-functional protein 1/p43: an emerging therapeutic protein working at systems level.

Authors:  Sang Won Lee; Gyuyoup Kim; Sunghoon Kim
Journal:  Expert Opin Drug Discov       Date:  2008-08       Impact factor: 6.098

Review 7.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

8.  Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathway.

Authors:  Ginat Narkis; Rivka Ofir; Esther Manor; Daniella Landau; Khalil Elbedour; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2007-07-24       Impact factor: 11.025

9.  Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway.

Authors:  Ginat Narkis; Rivka Ofir; Daniella Landau; Esther Manor; Micha Volokita; Relly Hershkowitz; Khalil Elbedour; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2007-07-24       Impact factor: 11.025

10.  Structural separation of different extracellular activities in aminoacyl-tRNA synthetase-interacting multi-functional protein, p43/AIMP1.

Authors:  Jung Min Han; Sang Gyu Park; Yeonsook Lee; Sunghoon Kim
Journal:  Biochem Biophys Res Commun       Date:  2006-02-02       Impact factor: 3.575

View more
  40 in total

Review 1.  Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping.

Authors:  Sunghoon Kim; Sungyong You; Daehee Hwang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.

Authors:  Haiming Xu; Nikolay L Malinin; Niranjan Awasthi; Roderich E Schwarz; Margaret A Schwarz
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

3.  High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease.

Authors:  B Bilir; Z Yapici; C Yalcinkaya; I Baris; C M B Carvalho; M Bartnik; B Ozes; M Eraksoy; J R Lupski; E Battaloglu
Journal:  Clin Genet       Date:  2012-02-20       Impact factor: 4.438

4.  AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onset.

Authors:  L Armstrong; R Biancheri; C Shyr; A Rossi; G Sinclair; C J Ross; M Tarailo-Graovac; W W Wasserman; C D M van Karnebeek
Journal:  Neurogenetics       Date:  2014-06-24       Impact factor: 2.660

5.  Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.

Authors:  Alexander Lossos; Nimrod Elazar; Israela Lerer; Ora Schueler-Furman; Yakov Fellig; Benjamin Glick; Bat-El Zimmerman; Haim Azulay; Shlomo Dotan; Sharon Goldberg; John M Gomori; Penina Ponger; J P Newman; Hodaifah Marreed; Andreas J Steck; Nicole Schaeren-Wiemers; Nofar Mor; Michal Harel; Tamar Geiger; Yael Eshed-Eisenbach; Vardiella Meiner; Elior Peles
Journal:  Brain       Date:  2015-07-15       Impact factor: 13.501

6.  Missense variants in AIMP1 gene are implicated in autosomal recessive intellectual disability without neurodegeneration.

Authors:  Zafar Iqbal; Lucia Püttmann; Luciana Musante; Attia Razzaq; Muhammad Yasir Zahoor; Hao Hu; Thomas F Wienker; Masoud Garshasbi; Zohreh Fattahi; Christian Gilissen; Lisenka E L M Vissers; Arjan P M de Brouwer; Joris A Veltman; Rolph Pfundt; Hossein Najmabadi; Hans-Hilger Ropers; Sheikh Riazuddin; Kimia Kahrizi; Hans van Bokhoven
Journal:  Eur J Hum Genet       Date:  2015-07-15       Impact factor: 4.246

7.  Homozygosity for a nonsense variant in AIMP2 is associated with a progressive neurodevelopmental disorder with microcephaly, seizures, and spastic quadriparesis.

Authors:  Anju Shukla; Aneek Das Bhowmik; Malavika Hebbar; Kadavigere V Rajagopal; Katta M Girisha; Neerja Gupta; Ashwin Dalal
Journal:  J Hum Genet       Date:  2017-11-16       Impact factor: 3.172

8.  Isolated foveal hypoplasia with secondary nystagmus and low vision is associated with a homozygous SLC38A8 mutation.

Authors:  Yonatan Perez; Libe Gradstein; Hagit Flusser; Barak Markus; Idan Cohen; Yshaia Langer; Mira Marcus; Tova Lifshitz; Rotem Kadir; Ohad S Birk
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

9.  Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.

Authors:  Michael Nafisinia; Nara Sobreira; Lisa Riley; Wendy Gold; Birgit Uhlenberg; Claudia Weiß; Corinne Boehm; Kristina Prelog; Robert Ouvrier; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2017-07-26       Impact factor: 4.246

10.  More than hypomyelination in Pol-III disorder.

Authors:  Adeline Vanderver; Davide Tonduti; Genevieve Bernard; Jinping Lai; Christopher Rossi; Giovanni Carosso; Martha Quezado; Kondi Wong; Raphael Schiffmann
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.